Anti leukaemia drug recognised with PM Prize for Innovation
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.
Showing 241 - 260 of 485 results
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.
In June 2022 Miles was appointed to a new role of Group Executive Nuclear Safety, Security and Stewardship with responsibility for all nuclear safety and security operations at ANSTO as well as coordination of al
Technology for enclosed spaces recently won global COVID19 NASA hackathon
The proof of concept for the approach used in the early development of the new gamma-ray imaging system has been published,
Frequently asked questions about the ANSTO Security Process, travel funding, ANSTO Research Portal and ACNS Customer Portal.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Protein found in tobacco plant can target and kill microorganisms,
Luis Abuel is a technical officer with a background in Instrumentation and Process Control Engineering. Luis started at ANSTO in May 2006 as an Instrumentation Technician in OPAL.
The independent nuclear regulator, ARPANSA, is currently accepting submissions about ANSTO’s planned $59.8 million Intermediate Level Solid Waste Storage Facility.
New high energy ion microprobe beamline supports space research on the effects of radiation on astronauts.
Minister for Industry and Science, the Hon Ed Husic MP has formally announced the appointment of a leading nuclear physicist, Professor Timothy Senden to the ANSTO Board.
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Experts at ANSTO’s Australian Synchrotron are prioritising work that could hold the key to fast-tracking the development of a vaccine for COVID-19.
Dr Jessica Hamilton, a beamline scientist at the Australian Synchrotron, has won the Falling Walls Lab competition hosted by the Australian Academy of Science for her 3 minute presentation on a novel approach to using mining waste for carbon dioxide capture and a source of carbonate minerals. The event is held to deliver solutions to some of the most promising challenges of our time.